SEC Info - Navidea Biopharmaceuticals, Inc. - ‘S-3’ on 8/25/20

SEC Info℠

Home

My Interests

Help

Please Sign In

Navidea Biopharmaceuticals, Inc. – ‘S-3’ on 8/25/20

On: Tuesday, 8/25/20, at 4:03pm ET · Accession #: 1437749-20-18666 · File #: 333-248404

Previous ‘S-3’: ‘S-3’ on 12/31/19 · Next: ‘S-3’ on 2/8/21 · Latest: ‘S-3’ on 8/29/23 · 28 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/25/20  Navidea Biopharmaceuticals, Inc.  S-3                    4:401K                                   RDG Filings/FA

Registration Statement – Securities for a Transaction — Form S-3 — SA’33
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3         Registration Statement - Securities for a           HTML    153K 
                Transaction                                                      
 2: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     69K 
 3: EX-5.1      Opinion of Counsel re: Legality                     HTML      9K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML      6K

Filing Submission 0001437749-20-018666 – SGML Text

Original SGML Text submitted by:	RDG Filings/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 401K ↑Top ↓Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20200825-160526	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20200825-160426	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20200825-160350	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001437749-20-018666
<TYPE>				S-3
<PUBLIC-DOCUMENT-COUNT>		7
<FILING-DATE>			20200825
<DATE-OF-FILING-DATE-CHANGE>	20200825

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		NAVIDEA BIOPHARMACEUTICALS, INC.
<CIK>				0000810509
<ASSIGNED-SIC>			2835
<IRS-NUMBER>			311080091  ⇒ 31-1080091
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			S-3
<ACT>				33
<FILE-NUMBER>			333-248404
<FILM-NUMBER>			201132296
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			4995 BRADENTON AVENUE
<STREET2>			SUITE 240
<CITY>				DUBLIN
<STATE>				OH
<ZIP>				43017
<PHONE>				6147937500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			4995 BRADENTON AVENUE
<STREET2>			SUITE 240
<CITY>				DUBLIN
<STATE>				OH
<ZIP>				43017
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		NEOPROBE CORP
<DATE-CHANGED>			19940714
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		S-3
<SEQUENCE>	1
<FILENAME>	navb20200824_s3.htm
<DESCRIPTION>	FORM S-3
<TEXT>
<html>
       Show <HTML>: 3,539 lines (widest: 2,302 characters) - 291K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-4.5
<SEQUENCE>	2
<FILENAME>	ex_201354.htm
<DESCRIPTION>	EXHIBIT 4.5
<TEXT>
<html>
       Show <HTML>: 872 lines (widest: 5,212 characters) - 98K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-5.1
<SEQUENCE>	3
<FILENAME>	ex_201355.htm
<DESCRIPTION>	EXHIBIT 5.1
<TEXT>
<html>
       Show <HTML>: 77 lines (widest: 1,395 characters) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		EX-23.2
<SEQUENCE>	4
<FILENAME>	ex_201356.htm
<DESCRIPTION>	EXHIBIT 23.2
<TEXT>
<html>
       Show <HTML>: 39 lines (widest: 959 characters) - 3K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	5  ⇐ Not a Document/Exhibit
<FILENAME>	navb20200824_s3img001.jpg
<TEXT>
       Show <TEXT>: 128 lines (Unix-to-Unix encoding) - 8K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	6  ⇐ Not a Document/Exhibit
<FILENAME>	thlogo01.jpg
<TEXT>
       Show <TEXT>: 273 lines (Unix-to-Unix encoding) - 17K bytes  
</TEXT>
</DOCUMENT>

<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	7  ⇐ Not a Document/Exhibit
<FILENAME>	thlogo02.jpg
<TEXT>
       Show <TEXT>: 320 lines (Unix-to-Unix encoding) - 20K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001437749-20-018666 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Navidea Biopharmaceuticals, Inc. – ‘S-3’ on 8/25/20

On: Tuesday, 8/25/20, at 4:03pm ET · Accession #: 1437749-20-18666 · File #: 333-248404

Registration Statement – Securities for a Transaction — Form S-3 — SA’33Filing Table of Contents

Registration Statement – Securities for a Transaction — Form S-3 — SA’33
Filing Table of Contents